Loading company…
Apeximmune Therapeutics Inc.
PrivateWon a federal SBIR/STTR research award from HHS and other federal agencies.
Department of Health and Human ServicesNational Institutes of Health
- SAM UEI
- LQVBQAEB9L23
- Founded
- —Source: [GOV]
- Headquarters
- South San Francisco, CaliforniaSource: [GOV]
- Country
- United StatesSource: [GOV]
- Headcount
- 10Source: [GOV]
- Stage
$0Source: [GOV]Total raised
UndisclosedSource: [GOV]Last valuation
Overview
Apeximmune Therapeutics Inc. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $399,618 in 2023. These are non-dilutive federal research grants, not equity financing. The company is based in South San Francisco, California.
Funding rounds
1 rounds1 round · latest SBIR Phase I award (HHS), Jun 2023
Sign in to see 1 rounds.
Sign inInvestors
No investors recorded yet for Apeximmune Therapeutics Inc..
Add an investorPeople
LeadershipAcquisitions
Apeximmune Therapeutics Inc. has no recorded acquisitions.
Add an acquisitionExits
Still private — no exit on record.
Record an exitDiversity investments
No diversity signals recorded yet for Apeximmune Therapeutics Inc..
Add diversity data